Emerita Professor Helen Foster
Dr Flora McErlane
| No evidence that genetic predictors of susceptibility predict changes in core outcomes in JIA | 2022 |
|
Dr Flora McErlane
| Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK | 2021 |
|
Dr Flora McErlane
| Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups | 2020 |
|
Emerita Professor Helen Foster
Dr Flora McErlane
| Comparing Proxy, Adolescent, and Adult Assessments of Functional Ability in Adolescents with Juvenile Idiopathic Arthritis | 2020 |
|
Dr Flora McErlane
Emerita Professor Helen Foster
| Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study | 2020 |
|
Dr Nicola Aldridge
Dr Flora McErlane
| Validation of novel patient-centred juvenile idiopathic arthritis-specific patient-reported outcome and experience measures (PROMs/PREMs) | 2020 |
|
Dr Josh Bennett
Dr Nicola Aldridge
Ravi Mistry
Dr Sharmila Jandial
Emerita Professor Helen Foster
et al. | Can quantitative MRI be used in the clinical setting to quantify the impact of intra-articular glucocorticoid injection on synovial disease activity in juvenile idiopathic arthritis? | 2019 |
|
Dr Flora McErlane
| Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis | 2019 |
|
Dr Flora McErlane
Emerita Professor Helen Foster
Dr Nicola Aldridge
| Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership | 2018 |
|
Dr Flora McErlane
Emerita Professor Helen Foster
| Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS) | 2018 |
|
Dr Flora McErlane
Emerita Professor Helen Foster
| Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trials | 2018 |
|
Dr Flora McErlane
Emerita Professor Helen Foster
| Effectiveness and safety of TNG inhibitors in adults with juvenile idiopathic arthritis | 2016 |
|
Emerita Professor Helen Foster
Dr Flora McErlane
| Estimates of Inactive Disease are Strongly Influenced by Outcome Definition in a Prospective Cohort of Patients with Juvenile Idiopathic Arthritis | 2016 |
|
Dr Flora McErlane
Emerita Professor Helen Foster
| Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study | 2016 |
|
Dr Flora McErlane
Emerita Professor Helen Foster
| Multicentre audit of disease activity assessment in JIA: JIA Topic Specific Group 2014 | 2015 |
|
Dr Flora McErlane
Emerita Professor Helen Foster
| Trends in Paediatric Rheumatology Referral Times and Disease Activity Indices over A Ten-Year Period among Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Prospective Study (CAPS) | 2014 |
|
Dr Flora McErlane
Emerita Professor Helen Foster
| Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register | 2013 |
|
Dr Flora McErlane
Emerita Professor Helen Foster
| Minimal Disease Activity in a Clinical Cohort of Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Prospective Study | 2013 |
|
Dr Flora McErlane
Emerita Professor Helen Foster
| Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis | 2013 |
|
Dr Flora McErlane
Dr John Davidson
Emerita Professor Helen Foster
| Does exlusion of the ESR for JADAS affect validity in the clinical setting in assessment of new-onset juvenile inflammatory arthritis? | 2012 |
|
Dr Flora McErlane
Emerita Professor Helen Foster
| Validation of JADAS in international league against rheumatism (ILAR) subtypes of juvenile idiopathic arthritis (JIA) | 2012 |
|
